BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Connoy A, Turner J, Núñez M. Levels of serum markers of liver inflammation and fibrosis in patients with chronic hepatitis C virus infection according to HIV status and antiretroviral use. AIDS Res Hum Retroviruses 2011;27:719-25. [PMID: 21128862 DOI: 10.1089/AID.2010.0224] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Cele SB, Odun-Ayo F, Onyangunga OA, Moodley J, Naicker T. Analysis of hepatocyte growth factor immunostaining in the placenta of HIV-infected normotensive versus preeclamptic pregnant women. Eur J Obstet Gynecol Reprod Biol 2018;227:60-6. [PMID: 29886319 DOI: 10.1016/j.ejogrb.2018.05.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 Budluang P, Pitchakarn P, Ting P, Temviriyanukul P, Wongnoppawich A, Imsumran A. Anti-inflammatory and anti-insulin resistance activities of aqueous extract from Anoectochilus burmannicus. Food Sci Nutr 2017;5:486-96. [PMID: 28572933 DOI: 10.1002/fsn3.416] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
3 Sodhi K, Bracero L, Feyh A, Nichols A, Srikanthan K, Latif T, Preston D, Shapiro JI, Elitsur Y. Role of Serum Biomarkers in Early Detection of Non-Alcoholic Steatohepatitis and Fibrosis in West Virginian Children. J Clin Cell Immunol 2016;7:393. [PMID: 27182456 DOI: 10.4172/2155-9899.1000393] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
4 López-Dupla M, Maymó-Masip E, Martínez E, Domingo P, Leal M, Peraire J, Viladés C, Veloso S, Arnedo M, Ferrando-Martínez S, Beltrán-Debón R, Alba V, Gatell JM, Vendrell J, Vidal F, Chacón MR. HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels. PLoS One 2015;10:e0144789. [PMID: 26658801 DOI: 10.1371/journal.pone.0144789] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
5 Sede M, Jones LR, Moretti F, Laufer N, Quarleri J. Inter and intra-host variability of hepatitis C virus genotype 1a hypervariable envelope coding domains followed for a 4-11 year of human immunodeficiency virus coinfection and highly active antiretroviral therapy. Virology 2014;471-473:19-28. [PMID: 25461527 DOI: 10.1016/j.virol.2014.09.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
6 Resino S, Sánchez-Conde M, Berenguer J. Coinfection by human immunodeficiency virus and hepatitis C virus: noninvasive assessment and staging of fibrosis. Curr Opin Infect Dis. 2012;25:564-569. [PMID: 22744318 DOI: 10.1097/qco.0b013e32835635df] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
7 Bricaire F, Valantin M. Inflammation et VIH. Bulletin de l'Académie Nationale de Médecine 2011;195:531-544. [DOI: 10.1016/s0001-4079(19)32062-x] [Reference Citation Analysis]